Riverview Capital Advisers’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,925
Closed -$255K 98
2025
Q1
$255K Hold
1,925
0.08% 83
2024
Q4
$218K Hold
1,925
0.07% 89
2024
Q3
$219K Hold
1,925
0.07% 82
2024
Q2
$200K Sell
1,925
-34
-2% -$3.6K 0.07% 82
2024
Q1
$223K Buy
1,959
+34
+2% +$3.9K 0.08% 80
2023
Q4
$212K Buy
+1,925
New +$192K 0.08% 78
2023
Q3
Sell
-1,925
Closed -$210K 80
2023
Q2
$210K Buy
+1,925
New +$205K 0.09% 78
2023
Q1
Sell
-1,925
Closed -$211K 81
2022
Q4
$211K Buy
+1,925
New +$199K 0.11% 71
2022
Q3
Sell
-1,925
Closed -$209K 74
2022
Q2
$209K Buy
1,925
+25
+1% +$2.84K 0.12% 78
2022
Q1
$225K Hold
1,900
0.1% 75
2021
Q4
$267K Buy
+1,900
New +$243K 0.12% 79

Other funds holding ABT

Riverview Capital Advisers's ABT Position: Q2 2025 in Review

Riverview Capital Advisers sold out of Abbott (ABT) in Q2 2025, closing a stake of 1,925 shares — an estimated $255K sold.

Riverview Capital Advisers first reported a position in ABT in Q4 2021 and held it in 11 quarters. The position peaked at $267K in Q4 2021. 3,185 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Riverview Capital Advisers reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • Riverview Capital Advisers sold 1,925 Abbott shares in Q2 2025, an estimated $255K.
  • Riverview Capital Advisers first reported a position in Abbott in Q4 2021 and held it in 11 quarters.
  • Riverview Capital Advisers's Abbott position peaked at $267K in Q4 2021.
  • 3,185 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Riverview Capital Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.